Impact of PEG and PEG- b -PAGE modified PLGA on nanoparticle formation, protein loading and release
- 1 March 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 500 (1-2) , 187-195
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/ neu by human dendritic cellsOncoImmunology, 2015
- Influence of PEG in PEG–PLGA microspheres on particle properties and protein releaseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsBiomaterials, 2011
- Quantifying drug release from PLGA nanoparticulatesEuropean Journal of Pharmaceutical Sciences, 2009
- The performance of nanocarriers for transmucosal drug deliveryExpert Opinion on Drug Delivery, 2006
- Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytesBiomaterials, 2005
- Particulate Delivery Systems for VaccinesCritical Reviews™ in Therapeutic Drug Carrier Systems, 2005
- Colloidal drug carriers: achievements and perspectivesCellular and Molecular Life Sciences, 2003
- Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactantsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes SystemJournal of Pharmaceutical Sciences, 1995